Antidepressants may cut death and heart disease risk in diabetes patients with depression

A large-scale study has found that regular antidepressant treatment may reduce the risk of death and heart disease in people with both depression and diabetes. The research, published in The Journal of Clinical Endocrinology & Metabolism, analysed data from over 36,000 patients and highlights the potential benefits of consistent medication use for this high-risk group. The study involved 36,276 patients and was led by researchers Shi-Heng Wang, Chi-Shin Wu, Le-Yin Hsu, and Yi-Jiun Pan. It found that those who took antidepressants as prescribed had a lower likelihood of dying or developing serious diabetes-related complications. These include heart disease, kidney problems, and other conditions often worsened by untreated depression.

Diabetes and depression frequently occur together, creating a cycle where each condition worsens the other. Depression can make it harder to manage blood sugar levels, increasing the risk of strokes, eye damage, and foot problems. Meanwhile, diabetes itself raises the chances of developing depression, further complicating treatment. The research was supported by funding from the Ministry of Science and Technology, China Medical University, and the Ministry of Health and Welfare. It appears in the Endocrine Society’s journal, which specialises in hormone-related conditions and metabolic disorders. The organisation, with over 18,000 members globally, includes scientists, doctors, and healthcare professionals working in endocrinology.

The findings suggest that sticking to antidepressant treatment could improve both survival rates and quality of life for people managing diabetes and depression. By reducing the risk of severe complications, consistent medication use may offer a practical way to break the harmful link between these two conditions.